The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis
- PMID: 19265129
- DOI: 10.4049/jimmunol.0800854
The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis
Abstract
Hypoxia is an essential component of tumor microenvironment. In this study, we investigated the influence of hypoxia (1% PO(2)) on CTL-mediated tumor cell lysis. We demonstrate that exposure of target tumor cells to hypoxia has an inhibitory effect on the CTL clone (Heu171)-induced autologous target cell lysis. Such inhibition correlates with hypoxia-inducible factor-1alpha (HIF-1alpha) induction but is not associated with an alteration of CTL reactivity as revealed by granzyme B polarization or morphological change. Western blot analysis indicates that although hypoxia had no effect on p53 accumulation, it induced the phosphorylation of STAT3 in tumor cells by a mechanism at least in part involving vascular endothelial growth factor secretion. We additionally show that a simultaneous nuclear translocation of HIF-1alpha and phospho-STAT3 was observed. Interestingly, gene silencing of STAT3 by small interfering RNA resulted in HIF-1alpha inhibition and a significant restoration of target cell susceptibility to CTL-induced killing under hypoxic conditions by a mechanism involving at least in part down-regulation of AKT phosphorylation. Moreover, knockdown of HIF-1alpha resulted in the restoration of target cell lysis under hypoxic conditions. This was further supported by DNA microarray analysis where STAT3 inhibition resulted in a partly reversal of the hypoxia-induced gene expression profile. The present study demonstrates that the concomitant hypoxic induction of phospho-STAT3 and HIF-1alpha are functionally linked to the alteration of non-small cell lung carcinoma target susceptibility to CTL-mediated killing. Considering the eminent functions of STAT3 and HIF-1alpha in the tumor microenvironment, their targeting may represent novel strategies for immunotherapeutic intervention.
Similar articles
-
A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells.Cancer Res. 2014 Feb 1;74(3):665-74. doi: 10.1158/0008-5472.CAN-13-0992. Epub 2013 Dec 13. Cancer Res. 2014. PMID: 24336068
-
Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression.Cancer Res. 2011 Sep 15;71(18):5976-86. doi: 10.1158/0008-5472.CAN-11-1094. Epub 2011 Aug 2. Cancer Res. 2011. PMID: 21810913
-
Hypoxia-dependent inhibition of tumor cell susceptibility to CTL-mediated lysis involves NANOG induction in target cells.J Immunol. 2011 Oct 15;187(8):4031-9. doi: 10.4049/jimmunol.1101011. Epub 2011 Sep 12. J Immunol. 2011. PMID: 21911602
-
Pathophysiological response to hypoxia - from the molecular mechanisms of malady to drug discovery:inflammatory responses of hypoxia-inducible factor 1α (HIF-1α) in T cells observed in development of vascular remodeling.J Pharmacol Sci. 2011;115(4):433-9. doi: 10.1254/jphs.10r22fm. Epub 2011 Mar 16. J Pharmacol Sci. 2011. PMID: 21422726 Review.
-
Mechanistic Justifications of Systemic Therapeutic Oxygenation of Tumors to Weaken the Hypoxia Inducible Factor 1α-Mediated Immunosuppression.Adv Exp Med Biol. 2019;1136:113-121. doi: 10.1007/978-3-030-12734-3_8. Adv Exp Med Biol. 2019. PMID: 31201720 Review.
Cited by
-
Interleukin-23 engineering improves CAR T cell function in solid tumors.Nat Biotechnol. 2020 Apr;38(4):448-459. doi: 10.1038/s41587-019-0398-2. Epub 2020 Feb 3. Nat Biotechnol. 2020. PMID: 32015548 Free PMC article.
-
The role of hypoxia in shaping the recruitment of proangiogenic and immunosuppressive cells in the tumor microenvironment.Contemp Oncol (Pozn). 2018 Mar;22(1A):7-13. doi: 10.5114/wo.2018.73874. Epub 2018 Mar 5. Contemp Oncol (Pozn). 2018. PMID: 29628788 Free PMC article. Review.
-
Normalizing Tumor Vasculature to Reduce Hypoxia, Enhance Perfusion, and Optimize Therapy Uptake.Cancers (Basel). 2021 Sep 3;13(17):4444. doi: 10.3390/cancers13174444. Cancers (Basel). 2021. PMID: 34503254 Free PMC article. Review.
-
Role of STAT3 in lung cancer.JAKSTAT. 2015 Jan 20;3(4):e999503. doi: 10.1080/21623996.2014.999503. eCollection 2014. JAKSTAT. 2015. PMID: 26413424 Free PMC article. Review.
-
Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer.J Mol Med (Berl). 2013 Feb;91(2):147-55. doi: 10.1007/s00109-013-1001-9. Epub 2013 Jan 20. J Mol Med (Berl). 2013. PMID: 23334369 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous